from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2472/-

LFCtreatmentdescriptionclass of inhibitor

-1.182

Amikacinug/mL Amikacintranslation

-0.490

Cap5-10ug/mL Capreomycintranslation

-0.386

Rox10-50 ug/mL Roxithromycintranslation

-0.137

SM2-5 ug/mL Streptomycintranslation

-0.576

Tet5-10 ug/mL Tetracyclinetranslation

-0.473

Rif0.2-5ug/mL Rifampicintranscription

0.296

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.417

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.063

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.088

CPZ10-50 ug/mL Chlorpromazinerespiration

0.451

Clofazimine10-13 ug/mL Clofaziminerespiration

0.148

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.695

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.131

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.125

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.417

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.086

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.136

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.667

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.345

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.669

KCN5-20 ug/mL Potassium cyaniderespiration

0.430

NaN30.2-2 mM Sodium aziderespiration

0.473

Nigericin50 uM Nigericinrespiration

-0.989

TRC10-150 ug/mL Triclosanrespiration

0.134

TRZ10-25 ug/mL Thioridazinerespiration

2.729

Valinomycin0.5-10 uM Valinomycinrespiration

2.162

ZnSO42 mM ZnSO4respiration

-0.727

menadione6-10 ug/mL Menadionerespiration

-0.327

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.347

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-1.004

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.195

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.798

NRP_1Non-replicating persistence stage 1dosRassociated

0.239

Amp0.2mg/mL AmpicillincellWall

-0.177

Cephalexin20-100 ug/mL CephalexincellWall

-0.047

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.496

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.387

EMB10-20 ug/mL EthambutolcellWall

0.104

Eta12-40 ug/mL EthionamidecellWall

-0.836

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.142

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.221

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.064

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.007

BZA0.12 mg/mL BenzamidearomaticAmides

0.469

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.250

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.071

H2O24 mM hydrogen peroxideDNAdamaging

-0.438

Levo10 ug/mL LevofloxacinDNAdamaging

-0.151

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.377

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.561

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.591

UVUV-irradiationDNAdamaging

0.040

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.705

Antimycin12.5-50 ug/mL Antimycin A?

-0.132

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.357

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.465

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.949

PA8240.2-2 ug/mL PA-824?

1.144

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.012

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.428

Verapamil50 uM Verapamil?

-0.031

mercaptoethanol2 mM 2-Mercaptoethanol?

0.398

methoxatin10-20 ug/mL Methoxatin?